AHRQ drug effectiveness research
Executive Summary
Initial results of the Agency for Healthcare Research & Quality's comparative effectiveness research mandated by the Medicare Modernization Act will be available in October, Center for Outcomes & Evidence Director Jean Slutsky said. The agency is beginning 12 studies on Medicare "priority conditions" using available data (1"The Pink Sheet" Dec. 20, 2004, p. 11)...
You may also be interested in...
AHRQ Drug Effectiveness Comparisons Will Focus On 10 “Priority Conditions”
Prescription drug comparative effectiveness research will proceed for 10 "priority conditions," thanks to $15 mil. provided by the fiscal year 2005 omnibus appropriations bill, the Agency for Healthcare Research & Quality said Dec. 15
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.